Global Poultry Vaccines Market Size, Trends, and Growth Opportunity, By Product Type (Modified or Attenuated (Live), Inactivated (Killed), and Recombinants), Disease Type (Newcastle Disease, Marek's Disease, Infectious Bronchitis, Infectious Bursal Disease, and Others), Application (Breeder, Broiler, Layer), Dosage Form (Liquid Vaccine, Freeze Dried Vaccine, and Duct (Dry Form), End-Users (Hospitals, Poultry Vaccination Centres, and Poultry Firms) By Region and forecast till 2030.
Global Poultry Vaccines Market
The global Poultry Vaccines Market was valued at USD 2.2 billion in 2022 and is slated to reach at USD 3.90 billion by 2030 at a CAGR of 7.42 % from 2023-2030.
A specific disease in poultry is prevented by vaccination, which dramatically speeds up the immune system's production of antibodies to fight the invaders. The control and prevention of poultry diseases are greatly aided by poultry vaccines. Most vaccines made from poultry are designed to combat viral diseases. These vaccinations are given in a variety of ways, including nasal, oral, ocular, intramuscular, in vivo, and subcutaneous.
Market Drivers
During the forecast period, market growth is anticipated to be boosted by the major players' expanding R&D efforts to introduce poultry vaccines to treat diseases and the expansion of product approvals. Venkys India, for example, offers a wide selection of poultry vaccines, such as the Salmonella polyvalent inactivated vaccine, which is used to prevent and treat salmonellosis in breeders, layers, and broilers. Additionally included in KM Biologics' product line, OILVAX EDS-76 has a strong anti-egg drop syndrome effect. This element contributes to market expansion. To strengthen their positions, several businesses involved in the poultry vaccine market are concentrating on introducing new technological solutions. For instance, the VAXXITEK HVT+IBD+ND vaccine was introduced in 2020 by the German pharmaceutical company Boehringer Ingelheim to safeguard poultry against three different diseases. The immune system is strengthened by VAXXITEK HVT+IBD+ND, which also provides enhanced defenses against Newcastle disease, Marek's disease, and infectious bursal disease (classic and variant types). This contributes to the expansion of the market.
Market Restraints
Products used in poultry vaccines have a wide range of side effects. Local side effects include head swelling, slight eye and nose discharge, localized pain and swelling at the injection site, decreased appetite and activity, sneezing, a mild fever, and mild coughing. This constraint prevents market growth.
Impact of COVID-19
Governments from all over the world are collaborating with pharmaceutical and biotech companies to combat the COVID-19 outbreak, from fostering the creation of vaccines to preparing for issues with the supply of medicines. In the R&D pipeline right now are about 155 molecules and 115 vaccine candidates. Additionally, the demand for commonly used medications like hydroxychloroquine has dramatically increased to treat COVID-19. Due to the shortage of these medications in many developed nations, the high demand for these medications has created enormous opportunities for producers of COVID-19 management medications. Future growth in the pharmaceutical and biotechnology sector is anticipated as a result of the demand for COVID-19 vaccines and treatment medications. The chicken vaccine market is being impacted by the ongoing COVID-19 pandemic. Due to the spread of infectious diseases, consumers are less willing to purchase poultry products, which slows the growth of the poultry market. This has an especially negative impact on the industries that produce vaccines and the demand and supply chains for those products.
Recent Developments
The VAXXITEK HVT+IBD+ND vaccine was introduced by Boehringer Ingelheim in 2020 to safeguard poultry against Marek's disease, Newcastle disease, and infectious bursal disease (classic and variant types). From its facility, where it creates more than 60 billion doses of poultry vaccine annually for use in the US and more than 60 other countries, Boehringer Ingelheim will manufacture VAXXITEK HVT+IBD+ND.
Market Segmentation
The global Poultry Vaccines Market is segmented By Product Type, Disease Type, Application, Dosage Form, and End-Users. By Product Types such as Modified or Attenuated (Live), Inactivated (Killed), and Recombinants. By Disease Types such as Newcastle Disease, Marek's Disease, Infectious Bronchitis, Infectious Bursal Disease, and Others. By Applications such as Breeder, Broiler, and Layer. By Dosage Forms such as Liquid Vaccine, Freeze Dried Vaccine, and Duct (Dry Form). By End-Users such as Hospitals, Poultry Vaccination Centres, and Poultry Firms.
Regional Analysis
The global Poultry Vaccines Market is segmented into five regions Americas, Europe, Asia-Pacific, and the Middle East & Africa. Due to rising investments in animal health and a persistent rise in demand for products made from poultry, Asia-Pacific is predicted to expand during the forecast period of the market for poultry vaccines. Additionally, the market is expanding due to the significant presence of top poultry-producing nations like China and a sizable population that consumes meat. Due to the market's dominance and the presence of key market players, North America will continue to experience rapid technological advancement during the forecast period. The growing number of government initiatives and enormous advancements in animal husbandry techniques are additional factors that are driving up demand for poultry vaccines in this region.
Key Players
This report includes a list of numerous Key Players, namely Boehringer Ingelheim International GmbH. (Germany), Novartis AG (Switzerland), Elanco (U.S.), Phibro Animal Health Corporation (U.S.), Zoetis (U.S.), Dechra Pharmaceuticals PLC (U.K.), Hester Biosciences Limited. (India), Merck & Co., Inc. (U.S.), Vaxxinova International BV, Venkys India.
Market Taxonomy
By Product Type
• Modified or Attenuated (Live)
• Inactivated (Killed)
• Recombinants
By Dosage Form
• Liquid Vaccine
• Freeze Dried Vaccine
• Duct
By Disease Type
• Newcastle Disease
• Marek's Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Others
By Application
• Breeder
• Broiler
• Layer
By End User
• Hospitals
• Poultry Vaccination Centres
• Poultry Firms
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa.
Global Poultry Vaccines Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Poultry Vaccines Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Poultry Vaccines Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Poultry Vaccines Market Share Analysis, By Product Type
5.3 Global Poultry Vaccines Market Size and Forecast, By Product Type
5.3.1 Modified or Attenuated (Live)
5.3.2 Inactivated (Killed)
5.3.3 Recombinants
6 Global Poultry Vaccines Market, By Dosage Form
6.1 Y-o-Y Growth Comparison, By Dosage Form
6.2 Global Poultry Vaccines Market Share Analysis, By Dosage Form
6.3 Global Poultry Vaccines Market Share Analysis, By Dosage Form
6.3.1 Liquid Vaccine
6.3.2 Freeze Dried Vaccine
6.3.3 Duct
7.Global Poultry Vaccines Market , By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Poultry Vaccines Market Share Analysis, By Application
7.3 Global Poultry Vaccines Market Share Analysis, By Application
7.3.1 Breeder
7.3.2 Broiler
7.3.3 Layer
8.Global Poultry Vaccines Market , By Disease Type
8.1 Y-o-Y Growth Comparison, By Disease Type
8.2 Global Poultry Vaccines Market Share Analysis, By Disease Type
8.3 Global Poultry Vaccines Market Share Analysis, By Disease Type
8.3.1 Newcastle Disease
8.3.2 Marek's Disease
8.3.3 Infectious Bronchitis
8.3.4 Infectious Bursal Disease
8.3.5 Others
9.Global Poultry Vaccines Market , By End User
9.1 Y-o-Y Growth Comparison, By End User
9.2 Global Poultry Vaccines Market Share Analysis, By End User
9.3 Global Poultry Vaccines Market Share Analysis, By End User
9.3.1 Hospitals
9.3.2 Poultry Vaccination Centres
9.3.3 Poultry Firms
10 Global Poultry Vaccines Market, By Region
10.1 Global Poultry Vaccines Market Share Analysis, By Region
10.2 Global Poultry Vaccines Market Share Analysis, By Region
11 North America Poultry Vaccines Market and Forecast (2023-2030)
11.1 Introduction
11.2 North America Poultry Vaccines Market Share Analysis, By Product Type
11.3 North America Poultry Vaccines Size and Forecast, By Dosage Form
11.4 North America Poultry Vaccines Market, By Application
11.5 North America Poultry Vaccines Market Size and Forecast, By Disease Type
11.6 North America Poultry Vaccines Market Share Analysis, By End User
11.7 North America Poultry Vaccines Market Size and Forecast, By Country
11.7.1 U.S
11.7.2 Canada
11.7.3 Mexico
12 Europe Poultry Vaccines Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Europe Poultry Vaccines Market Share Analysis, By Product Type
12.3 Europe Poultry Vaccines Market Size and Forecast, By Dosage Form
12.4 Europe Poultry Vaccines Market, By Application
12.5 Europe Poultry Vaccines Market Size and Forecast, By Disease Type
12.6 Europe Poultry Vaccines Market Share Analysis, By End User
10.7 Europe Poultry Vaccines Market Size and Forecast, By Country
12.7.1 Germany
12.7.2 France
12.7.3 UK
12.7.4 Rest of Europe
13 Asia Pacific Poultry Vaccines Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Asia-Pacific Poultry Vaccines Market Size and Forecast, By Product Type
13.3 Asia-Pacific Poultry Vaccines Market Size and Forecast, By Dosage Form
13.4 Asia-Pacific Poultry Vaccines Market, By Application
13.5 Asia-Pacific Poultry Vaccines Market Size and Forecast, By Disease Type
13.6 Asia-Pacific Poultry Vaccines Market Share Analysis, By End User
11.7 Asia-Pacific Poultry Vaccines Market Size and Forecast, By Country
11.7.1 China
11.7.2 Japan
11.7.3 India
11.5.4. Rest of Asia Pacific
14 Latin America Poultry Vaccines Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Latin America Poultry Vaccines Market Size and Forecast, By Product Type
14.3 Latin America Poultry Vaccines Market Size and Forecast, By Dosage Form
14.4 Latin America Poultry Vaccines Market , By Application
14.5 Latin America Poultry Vaccines Market Size and Forecast, By Disease Type
14.6 Latin America Poultry Vaccines Market Share Analysis, By End User
14.7 Latin America Poultry Vaccines Market Size and Forecast, By Country
14.7.1 Brazil
14.7.2.Rest of Latin America
15 Middle East Poultry Vaccines Market Analysis and Forecast (2022-2030)
15.1 Introduction
15.2 Middle East Poultry Vaccines Market Share Analysis, By Product Type
15.3 Middle East Poultry Vaccines Market Size and Forecast, By Dosage Form
15.4 Middle East Poultry Vaccines Market, By Application
15.5 Middle East Poultry Vaccines Market Size and Forecast, By Disease Type
15.6 Middle East Poultry Vaccines Market Share Analysis, By End User
15.7 Middle East Poultry Vaccines Market Size and Forecast, By Country
15.7.1. Saudi Arabia
15.7.2. UAE
15.7.2. Egypt
15.7.4. Kuwait
15.7.5. South Africa
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1. Boehringer Ingelheim International GmbH. (Germany)
17.1.1 Overview
17.1.2 Offerings
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2. Novartis AG (Switzerland)
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3. Elanco (U.S.)
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4. Phibro Animal Health Corporation (U.S.)
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5. Zoetis (U.S.)
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6. Dechra Pharmaceuticals PLC (U.K.)
17.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7. Hester Biosciences Limited. (India)
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8. Merck & Co., Inc. (U.S.)
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9. Vaxxinova International BV
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10. Venkys India
17.10.1 Overview
17.10.2 Offerings
17.10.3 Key Financials
17.10.4 Business Segment & Geographic Overview
17.10.5 Key Market Developments
17.10.6 Key Strategies
